The overall objectives of the Gastrointestinal Immunology Core Laboratory are to provide assays of gastrointestinal or hepatic immune function relevant to GI research to Digestive Diseases Center (DDC) investigators, to make available specialized cell sorting and quantitative cytokine laboratory facilities to GI researchers, and to develop new quantitative tests for the evaluation of mRNA and protein for cytokines or other inflammatory mediators that may be useful in clinical and basic research. Major core services include: (1) state-of-the-art techniques in flow cytometry, rare event analysis and high-speed cell sorting; (2) isolation of immune/inflammatory cells from the gastrointestinal tract and liver, (3) quantitative RT-PCR and gene expression analysis for cytokines and other inflammatory mediators, (4) analysis of cytokine protein and cytokine-producing cells, and (5) functional analysis of gastrointestinal immune and inflammatory cells or factors. The core will also provide training and technical advice to researchers interested in developing sophistical immunology procedures for their GI-related research projects. For example, studies on the immunopathologies of disease in the gastrointestinal tract or liver in humans or animal models; development of gene array techniques relevant to immunity and inflammation or; approaches to assess and characterize the host response in normal tissue or a specific model of GI disease. Thus, the Core will benefit the Center members with a regular service and exchange of information in order to facilitate GI research development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
3P30DK056338-02S1
Application #
6655203
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-03-01
Project End
2003-02-28
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Graham, David Y; Dore, Maria Pina; Lu, Hong (2018) Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies. Expert Rev Anti Infect Ther 16:679-687
Jarrett, Kelsey E; Lee, Ciaran; De Giorgi, Marco et al. (2018) Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research. Arterioscler Thromb Vasc Biol 38:1997-2006
Call, Lee; Stoll, Barbara; Oosterloo, Berthe et al. (2018) Metabolomic signatures distinguish the impact of formula carbohydrates on disease outcome in a preterm piglet model of NEC. Microbiome 6:111
Yuan, Xiaoyi; Lee, Jae W; Bowser, Jessica L et al. (2018) Targeting Hypoxia Signaling for Perioperative Organ Injury. Anesth Analg 126:308-321
Donaldson, G P; Ladinsky, M S; Yu, K B et al. (2018) Gut microbiota utilize immunoglobulin A for mucosal colonization. Science 360:795-800
White, Donna L; Hoogeveen, Ron C; Chen, Liang et al. (2018) A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med 7:2180-2191
Wang, Changjun; Zaheer, Mahira; Bian, Fang et al. (2018) Sjögren-Like Lacrimal Keratoconjunctivitis in Germ-Free Mice. Int J Mol Sci 19:
Blutt, Sarah E; Crawford, Sue E; Ramani, Sasirekha et al. (2018) Engineered Human Gastrointestinal Cultures to Study the Microbiome and Infectious Diseases. Cell Mol Gastroenterol Hepatol 5:241-251
Yu, Wangie; Chen, Yunyun; Dubrulle, Julien et al. (2018) Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Sci Rep 8:4306
Mindikoglu, Ayse L; Pappas, Stephen C (2018) Predictors of Response to Terlipressin in Hepatorenal Syndrome. Clin Gastroenterol Hepatol 16:1174

Showing the most recent 10 out of 1121 publications